Stage III Renal Cell Cancer Completed Phase 2 Trials for Doxorubicin (DB00997)

IndicationStatusPhase
DBCOND0028847 (Stage III Renal Cell Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00335556Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney TumorsTreatment